MedTrace Logo

Technology-supported Motor Rehabilitation for People With Rett Syndrome

NCT07418905 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2026-02-20

No results posted yet for this study

Summary

This study focuses on improving purposeful arm use while simultaneously reducing engagement in stereotypies. It is typically expected that the training period for this study will last about 6 months. The first half of the training periods will be devoted to learning to separate hands to stop the stereotypies that interfere with arm and hand use. In this first half, participants will also need to learn to keep arms apart in order to be actively involved in the chosen game. The second half of the training period will be devoted to learning to stop stereotypies and reach for targets that are intended to start game play. When not touching the targets, the software will interpret that the game should stop and wait for the next target to be touched.

Conditions

Interventions

BEHAVIORAL

computer gaming

Investigators will personalize gaming sessions based on the motivators and interests of each participant. During each intervention session, the participant will be encouraged to initiate voluntary hand separations in order to activate or control the gaming activity.

Sponsors & Collaborators

  • Fraunhofer Heinrich Hertz Institut (HHI)

    collaborator UNKNOWN

  • Max-Planck-Institute for Cognition

    collaborator UNKNOWN

  • Charite University, Berlin, Germany

    collaborator OTHER

  • Rett Syndrome of Germany

    collaborator UNKNOWN

  • Georgetown University

    lead OTHER

Principal Investigators

  • Pamela Diener, PhD,MS,OT/L · Georgetown University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07418905 on ClinicalTrials.gov